Predicting Response to Risperidone Treatment Through Identification of Early-Onset of Antipsychotic Drug Action in Schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 01 May 2010
At a glance
- Drugs Olanzapine; Risperidone
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 01 Jan 2010 Results reported in Neuropsychopharmacology.
- 01 Jan 2010 Secondary endpoint 'Montgomery Asberg Depression Rating Scale' has been met.
- 01 Jan 2010 Primary endpoint 'Positive and Negative Syndrome Scale' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History